Hepatic steatosis and type 2 diabetes mellitus.

被引：98

作者：

Clark J.M. ^{[1
]}

Diehl A.M. ^{[1
]}

机构：

[1] Department of Medicine, Johns Hopkins University School of Medicine, 912 Ross Building, 720 Rutland Street, Baltimore, 21205, MD

来源：

Current Diabetes Reports | 2002年 / 2卷 / 3期

关键词：

Insulin Resistance; Metformin; Fatty Liver; Hepatic Steatosis; Fatty Liver Disease;

D O I：

10.1007/s11892-002-0085-3

中图分类号：

学科分类号：

摘要：

Type 2 diabetes is strongly associated with nonalcoholic fatty liver disease (NAFLD), a spectrum of liver damage that ranges from relatively benign hepatic steatosis to potentially fatal cirrhosis. The severities of insulin resistance and liver damage parallel each other, with the greatest prevalence of cirrhosis occurring in cirrhotics. However, it is unknown whether one of these conditions causes the other, or if both are consequences of another process. Experimental evidence suggests that both insulin resistance and NAFLD result from a chronic inflammatory state. The mechanisms driving this chronic inflammation are unknown but might include the egress of products from intestinal bacteria into the portal blood, liver, and systemic circulation to trigger a sustained inflammatory cytokine response in genetically susceptible individuals. More research is needed to evaluate this hypothesis and to determine the benefits of treatments that interrupt this pathogenic cascade.

引用

页码：210 / 215

页数：5

共 148 条

[1] Harris MI(1998)Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults Diabetes Care 21 518-524
[2] Elegal KM(1991)Cause-specific mortality in a population-based study of diabetes Am J Public Health 81 1158-1162
[3] Cowie CC(1980)Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease Mayo Clin Proc 55 342-348
[4] Moss SE(1999)Nonalcoholic fatty liver disease: a spectrum of clinical pathological severity Gastroenterology 116 1413-1419
[5] Klein R(1999)Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 664-669
[6] Klein BE(2001)Clinical features and natural history of nonalcoholic steatosis syndromes Semin Liver Dis 21 71-76
[7] Ludwig J(1994)Prevalence of chronic liver disease in the general population of northern Italy: the Dyonisos study Hepatology 20 1442-1449
[8] Viggiano RT(1988)Prevalence of fatty liver in a general population of Okinawa, Japan Jpn J Med 27 142-149
[9] McGill DB(1987)Compensated cirrhosis: natural history and prognostic factors Hepatology 7 122-128
[10] Matteoni C(1958)The liver in obesity Arch Intern Med 90 141-156

← 1 2 3 4 5 6 7 8 9 10 →